Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biochem Cell Biol ; 42(8): 1355-62, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20619223

ABSTRACT

Distinguishing hepatocellular carcinoma from metastatic tumors in the liver is of great practical importance, with significant therapeutic and prognostic implications. This differential diagnosis can be difficult because metastatic cancers in the liver, especially adenocarcinomas, may mimic the morphology and immunoexpression of hepatocellular carcinoma. Biomarkers that are specifically expressed in either hepatocellular carcinoma or metastatic adenocarcinoma can therefore be useful diagnostic tools. To find such biomarkers, we studied microRNA expression in 144 tumor samples using custom microarrays. Hsa-miR-141 and hsa-miR-200c, microRNAs that promote epithelial phenotypes, had significantly higher levels in non-hepatic epithelial tumors. In contrast, endothelial-associated hsa-miR-126 showed higher expression levels in hepatocellular carcinomas. Combinations of these microRNAs accurately identified primary hepatocellular carcinoma from metastatic adenocarcinoma in the liver. These findings were validated using quantitative real-time PCR to measure microRNA expression in additional samples. Thus, the tissue-specific expression patterns of microRNAs make them useful biomarkers for the diagnosis of liver malignancies.


Subject(s)
Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/genetics , Gene Expression Regulation, Neoplastic , Liver Neoplasms/diagnosis , Liver Neoplasms/genetics , Liver/metabolism , MicroRNAs/genetics , Carcinoma, Hepatocellular/pathology , Diagnosis, Differential , Humans , Liver/pathology , Liver Neoplasms/pathology , MicroRNAs/metabolism , Neoplasm Metastasis , ROC Curve , Reverse Transcriptase Polymerase Chain Reaction
2.
Mod Pathol ; 23(6): 814-23, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20348879

ABSTRACT

Identification of the tissue of origin of a tumor is vital to its management. Previous studies showed tissue-specific expression patterns of microRNA and suggested that microRNA profiling would be useful in addressing this diagnostic challenge. MicroRNAs are well preserved in formalin-fixed, paraffin-embedded (FFPE) samples, further supporting this approach. To develop a standardized assay for identification of the tissue origin of FFPE tumor samples, we used microarray data from 504 tumor samples to select a shortlist of 104 microRNA biomarker candidates. These 104 microRNAs were profiled by proprietary quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) on 356 FFPE tumor samples. A total of 48 microRNAs were chosen from this list of candidates and used to train a classifier. We developed a clinical test for the identification of the tumor tissue of origin based on a standardized protocol and defined the classification criteria. The test measures expression levels of 48 microRNAs by qRT-PCR, and predicts the tissue of origin among 25 possible classes, corresponding to 17 distinct tissues and organs. The biologically motivated classifier combines the predictions generated by a binary decision tree and K-nearest neighbors (KNN). The classifier was validated on an independent, blinded set of 204 FFPE tumor samples, including nearly 100 metastatic tumor samples. The test predictions correctly identified the reference diagnosis in 85% of the cases. In 66% of the cases the two algorithm predictions (tree and KNN) agreed on a single-tissue origin, which was identical to the reference diagnosis in 90% of cases. Thus, a qRT-PCR test based on the expression profile of 48 tissue-specific microRNAs allows accurate identification of the tumor tissue of origin.


Subject(s)
Biomarkers, Tumor/genetics , Gene Expression Profiling/methods , Gene Expression Regulation, Neoplastic , Genetic Testing/methods , MicroRNAs/analysis , Neoplasms, Unknown Primary/diagnosis , Reverse Transcriptase Polymerase Chain Reaction , Algorithms , Decision Trees , Germany , Humans , Israel , Neoplasms, Unknown Primary/genetics , Oligonucleotide Array Sequence Analysis , Predictive Value of Tests , Reproducibility of Results , Sensitivity and Specificity , United States
3.
Biochim Biophys Acta ; 1802(2): 235-9, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19835953

ABSTRACT

OBJECTIVE: To examine the effects of rosiglitazone in intramyocellular lipid (IMCL) content in diabetic Psammomys obesus using novel electron microscopy technologies. BACKGROUND: P. obesus is an unique polygenic model of obesity and type 2 diabetes. Male diabetic P. obesus were treated daily with 5 mg/Kg Rosiglitazone by oral gavage for 14 days. Data were compared with a group of age-matched diabetic P. obesus treated with saline vehicle. METHODS: Assessment of insulin resistance and adiposity were determine before and after the treatment period by oral glucose tolerance test (oGTT) and dual energy X-ray absorptiometry (DEXA) analysis. We used a new scanning electron microscopy technology, (WETSEM) to investigate the effects of rosiglitazone administration on IMCL content, size and distribution in red gastrocnemius muscle. RESULTS: Rosiglitazone treatment improved glucose tolerance in P. obesus with no difference in the overall body fat content although a significant reduction in subscapular fat mass was observed. Rosiglitazone changed the distribution of lipid droplet size in skeletal muscle. Treated animals tended to have smaller lipid droplets compared with saline-treated controls. CONCLUSIONS: Since smaller IMCL droplets are associated with improvements in insulin sensitivity, we propose that this may be an important mechanism by which rosiglitazone affects glucose tolerance.


Subject(s)
Intracellular Space/metabolism , Lipids/physiology , Thiazolidinediones/pharmacology , Adipose Tissue/anatomy & histology , Adipose Tissue/drug effects , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight , Dietary Carbohydrates/pharmacology , Gerbillinae , Glucose Tolerance Test , Hyperglycemia/chemically induced , Hyperglycemia/metabolism , Hypoglycemic Agents/pharmacology , Insulin/blood , Intracellular Space/drug effects , Male , Rosiglitazone
4.
Obesity (Silver Spring) ; 16(3): 695-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18239599

ABSTRACT

OBJECTIVE: To evaluate the accumulation pattern of intramyocellular lipids (IMCLs) in striated muscle during the development and progression of diabetes, using a novel scanning electron microscopic method. METHODS AND PROCEDURES: Hyperglycemia was induced by feeding diabetes-prone (DP) Psammomys obesus a high-energy (HE) diet. Lipid accumulation within gastrocnemius muscle fibers was assessed in formalin-fixed muscle samples during the development of hyperglycemia using high resolution imaging in a scanning electron microscope. We evaluated the temporal relationship between changes in IMCL quantity and morphology and the altered glucose metabolism and assessed the effect of reversal of hyperglycemia on IMCL level and morphology. Diabetes-resistant (DR) P. obesus served as controls. RESULTS: Lipid accumulation in the muscle fibers of DP animals was increased with the development of hyperglycemia. This was characterized by increased lipid density as well as by an abundance of large lipid droplets. Reversal of the phenotype resulted in the disappearance of large lipid droplets. The IMCL level and the distribution of lipid droplet size were similar in muscles of both the normoglycemic DR and DP animals, with an abundance of small lipid droplets. This profile was changed following a HE diet only in the DP animals. DISCUSSION: Lipid accumulation in the muscle of P. obesus during the development of hyperglycemia is characterized by increased quantity and accumulation of large lipid droplets. These changes were reversible upon normalization of blood glucose. The evaluated methodology is a useful tool for the study of the dynamics of lipid accumulation in different metabolic conditions.


Subject(s)
Diabetes Mellitus, Type 2/pathology , Hyperglycemia/pathology , Lipid Metabolism , Microscopy, Electron, Scanning , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/ultrastructure , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/metabolism , Disease Models, Animal , Disease Progression , Energy Intake , Gerbillinae , Hyperglycemia/metabolism , Insulin/blood , Male , Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/metabolism , Phenotype , Time Factors
5.
Obesity (Silver Spring) ; 15(7): 1657-65, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17636083

ABSTRACT

OBJECTIVE: To evaluate a new scanning electronic microscopic (EM) method for assessing fat cell sizes and compare fat cell size distribution in human adipose tissue from different fat depots before and after weight loss. RESEARCH METHODS AND PROCEDURES: Identical human fat tissue biopsies were separated into two fractions: one used to prepare a fat cell suspension by collagenase digestion followed by photomicrography (collagenase method) and the other fixed in formalin for EM analysis. The EM method was evaluated further by determining fat cell sizes from lean and ob/ob mice. Finally, the EM method was used to assess fat cell sizes in biopsies of different human depots from before and after weight loss. RESULTS: Fat cell size distributions measured by the two methods were not identical, but differences were generally small. The EM method reproduced the well-documented fat cell size difference between lean and ob/ob mice. Large variation was detected in fat cell distributions among three depots in humans. Weight loss reduced fat cell sizes in subjects with large baseline fat cells but had no effect in subjects with small baseline fat cell sizes. DISCUSSION: Our results suggest that the EM method may be a useful alternative for fat cell size analysis of clinical samples.


Subject(s)
Adipocytes/ultrastructure , Adipose Tissue/ultrastructure , Animals , Humans , Mice , Microscopy, Electron, Scanning/methods , Obesity/pathology , Weight Loss
6.
Exp Toxicol Pathol ; 57(4): 291-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16413765

ABSTRACT

Development of effective therapies for multiple sclerosis (MS) is dependent on the advancement of improved tools for evaluation of progression of this disease in animal models. We present a novel technique utilizing scanning electron microscopy (SEM) for imaging wet biological specimens thus enabling rapid and high-resolution imaging of myelin in mouse spinal cord (SC). We demonstrate the advantages of using the wet SEM technique to image myelin in a murine model of MS, experimental autoimmune encephalomyelitis (EAE) induced in the Biozzi (antibody-high) mouse, by sensitization with spinal cord homogenate (SCH) in adjuvant. Our studies show that the methodology allows easy identification of normal and pathological components with great clarity, which is then correlated with light microscopy (LM) and validated thereby. Furthermore, we demonstrate gold immunolabeling of specific epitopes. We conclude that the new technique provides a quick, accurate, and detailed structural evaluation of the SC that can be applied to advance the research of MS.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/pathology , Microscopy, Electron, Scanning/methods , Multiple Sclerosis/pathology , Myelin Sheath/ultrastructure , Spinal Cord/ultrastructure , Animals , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/immunology , Female , Mice , Mice, Inbred Strains , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...